Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.46 USD | 0.00% | -8.89% | -37.34% |
May. 13 | Morgan Stanley Lowers Price Target on NeuroPace to $9.50 From $13, Keeps Equalweight Rating | MT |
May. 08 | NeuroPace, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-37.34% | 186M | |
+7.32% | 217B | |
+13.83% | 195B | |
+20.48% | 144B | |
+31.33% | 112B | |
+3.80% | 65.83B | |
+14.64% | 52.67B | |
+2.72% | 49.86B | |
-5.88% | 38.18B | |
+0.25% | 35.39B |
- Stock Market
- Equities
- NPCE Stock
- News NeuroPace, Inc.
- Transcript : NeuroPace, Inc., Q1 2024 Earnings Call, May 08, 2024